Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room H, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Effects of Parecoxib, a Parenteral COX-2 Specific Inhibitor, on the Disposition of Midazolam : A-529
Anesthesiology, University of Washington, Seattle, WA, United States
Anesthesiology September 2000, Vol. 93, A–529.
Citation
Andra Ibrahim, Aziz Karim, Jennifer Feldman, Evan Kharasch; Room H, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Effects of Parecoxib, a Parenteral COX-2 Specific Inhibitor, on the Disposition of Midazolam : A-529. Anesthesiology 2000; 93:A–529 doi: https://doi.org/10.1097/00000542-200009001-00529
Download citation file:
156
Views
Citing articles via
Most Viewed
Related Articles
Effects of Parecoxib, a Parenteral COX-2-specific Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Propofol
Anesthesiology (January 2002)
Simultaneous Assessment of Drug Interactions with Low- and High-Extraction Opioids: Application to Parecoxib Effects on the Pharmacokinetics and Pharmacodynamics of Fentanyl and Alfentanil
Anesthesiology (April 2003)
Development of a Population Pharmacokinetic Model for Parecoxib and Its Active Metabolite Valdecoxib after Parenteral Parecoxib Administration in Children
Anesthesiology (May 2012)